192 related articles for article (PubMed ID: 31210040)
1. Transcranial brain sonography for Parkinsonian syndromes.
Bor-Seng-Shu E; Paschoal FM; Almeida KJ; De Lima Oliveira M; Nogueira RC; Teixeira MJ; Walter U
J Neurosurg Sci; 2019 Aug; 63(4):441-449. PubMed ID: 31210040
[TBL] [Abstract][Full Text] [Related]
2. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
[TBL] [Abstract][Full Text] [Related]
3. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
Busse K; Heilmann R; Kleinschmidt S; Abu-Mugheisib M; Höppner J; Wunderlich C; Gemende I; Kaulitz L; Wolters A; Benecke R; Walter U
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):441-7. PubMed ID: 22362921
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
5. Place value of transcranial sonography in early diagnosis of Parkinson's disease.
Berg D; Gaenslen A
Neurodegener Dis; 2010; 7(5):291-9. PubMed ID: 20616564
[TBL] [Abstract][Full Text] [Related]
6. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease.
Walter U; Dressler D; Wolters A; Wittstock M; Benecke R
Mov Disord; 2007 Jan; 22(1):48-54. PubMed ID: 17083096
[TBL] [Abstract][Full Text] [Related]
7. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].
Mijajlović M; Petrović I; Stojković T; Svetel M; Stefanova E; Kostić VS
Vojnosanit Pregl; 2008 Aug; 65(8):601-5. PubMed ID: 18751340
[TBL] [Abstract][Full Text] [Related]
8. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U
Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617
[TBL] [Abstract][Full Text] [Related]
9. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.
Walter U
Expert Rev Neurother; 2009 Jun; 9(6):835-46. PubMed ID: 19496687
[TBL] [Abstract][Full Text] [Related]
10. Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.
Laučkaitė K; Rastenytė D; Šurkienė D; Vaitkus A; Sakalauskas A; Lukoševičius A; Gleiznienė R
BMC Neurol; 2012 Mar; 12():12. PubMed ID: 22400906
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound in the (premotor) diagnosis of Parkinson's disease.
Berg D
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S429-33. PubMed ID: 18267277
[TBL] [Abstract][Full Text] [Related]
12. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes.
Walter U; Niehaus L; Probst T; Benecke R; Meyer BU; Dressler D
Neurology; 2003 Jan; 60(1):74-7. PubMed ID: 12525721
[TBL] [Abstract][Full Text] [Related]
13. Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study.
Mahlknecht P; Stockner H; Marini K; Gasperi A; Djamshidian A; Willeit P; Kiechl S; Willeit J; Rungger G; Poewe W; Seppi K
Parkinsonism Relat Disord; 2020 Jan; 70():51-54. PubMed ID: 31864071
[TBL] [Abstract][Full Text] [Related]
14. Transcranial brain parenchyma sonography in movement disorders: state of the art.
Walter U; Behnke S; Eyding J; Niehaus L; Postert T; Seidel G; Berg D
Ultrasound Med Biol; 2007 Jan; 33(1):15-25. PubMed ID: 17189043
[TBL] [Abstract][Full Text] [Related]
15. Transcranial sonography in the early and differential diagnosis of Parkinson's disease.
Berg D
J Neural Transm Suppl; 2006; (70):249-54. PubMed ID: 17017537
[TBL] [Abstract][Full Text] [Related]
16. Transcranial sonography in the premotor diagnosis of Parkinson's disease.
Behnke S; Schröder U; Berg D
Int Rev Neurobiol; 2010; 90():93-106. PubMed ID: 20692496
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis of Parkinson's disease.
Gaenslen A; Berg D
Int Rev Neurobiol; 2010; 90():81-92. PubMed ID: 20692495
[TBL] [Abstract][Full Text] [Related]
19. The role of substantia nigra sonography in the differentiation of Parkinson's disease and multiple system atrophy.
Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Tan YY; Chen SD
Transl Neurodegener; 2018; 7():15. PubMed ID: 30062008
[TBL] [Abstract][Full Text] [Related]
20. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
